je.st
news
Tag: receiving
Minneapolis Homes Now Receiving Carts to Recycle Organics
2015-08-10 21:21:00| Waste Age
StarTribune.com Green carts that can be filled with fruit scraps, pizza boxes, chicken bones, cotton balls and other compostable waste began hitting the curb in Minneapolis on Monday morning. read more
Tags: homes
receiving
minneapolis
recycle
MM-398 Receiving The Priority Review Designation By US FDA For New Drug Application And The Acceptance Of Market Authorization Application By EMA In Post-Gemcitabine Metastatic Pancreatic Cancer
2015-07-01 08:52:42| drugdiscoveryonline Home Page
PharmaEngine, Inc. (TWO: 4162) announced that (1) its license partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), has received the notification from the US Food and Drug Administration (FDA) for the acceptance and the grant of the priority review designation for their New Drug Application (NDA); and (2) its sublicense partner, Baxalta Incorporated, a wholly owned subsidiary of Baxter International Inc. (NYSE: BAX) has received the acceptance of Market Authorization Application (MAA) from the European Medicines Agency (EMA), of MM-398 (irinotecan liposome injection, also known as "nal-IRI,") in the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy
Tags: review
market
application
drug
Merck Announces Phase 3 Study of Single-Dose EMEND (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint in Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy
2015-06-29 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from a Phase 3 study investigating the safety and efficacy of single-dose EMEND (fosaprepitant dimeglumine) for Injection, Mercks substance P/neurokinin (NK-1) receptor antagonist, in combination with other anti-vomiting medicines, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in adult cancer patients receiving moderately emetogenic (vomit-inducing) chemotherapy (MEC). Language: English Contact: MerckMedia:Doris Li, 908-740-1903orAn Phan, 908-255-6325orInvestor:Joseph Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Effective Coal Material Handling from Distribution to Receiving
2015-06-17 01:00:00| Power Technology
En-Masse Drag Chain Conveying technology offers advantages over other conveying types for coal handling, due to its effective utilisation of space, totally enclosed housing, and ability to operate effectively horizontally or vertically.
Tags: material
effective
distribution
handling
Septage Receiving System offers automated rock removal.
2015-04-27 14:31:07| Industrial Newsroom - All News for Today
With SPIRALIFT® SR Septage Receiving System, TASKMASTER TT grinder uses trap system to settle out rocks with high level of efficiency. Automated rock removal option has automated gate valve that opens on pre-planned cycle and lets rocks fall into enclosed screw conveyor. They are then conveyed directly into bin for disposal without operator assistance. System is preferred by plants that do not want to remove rocks manually.
Tags: system
offers
rock
receiving
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] next »